

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 5.09045591 |
| 2 | cytidine metabolic process (GO:0046087) | 5.09045591 |
| 3 | cytidine catabolic process (GO:0006216) | 5.09045591 |
| 4 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.48841218 |
| 5 | DNA demethylation (GO:0080111) | 4.36136529 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 4.20387787 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 4.20387787 |
| 8 | tryptophan catabolic process (GO:0006569) | 4.20387787 |
| 9 | DNA deamination (GO:0045006) | 4.01375573 |
| 10 | kynurenine metabolic process (GO:0070189) | 3.98220465 |
| 11 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.95462716 |
| 12 | T cell migration (GO:0072678) | 3.86859463 |
| 13 | amine catabolic process (GO:0009310) | 3.82803470 |
| 14 | cellular biogenic amine catabolic process (GO:0042402) | 3.82803470 |
| 15 | response to type I interferon (GO:0034340) | 3.68896194 |
| 16 | cellular response to type I interferon (GO:0071357) | 3.66126225 |
| 17 | type I interferon signaling pathway (GO:0060337) | 3.66126225 |
| 18 | positive regulation of defense response to virus by host (GO:0002230) | 3.46571454 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.46072503 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.45888572 |
| 21 | tryptophan metabolic process (GO:0006568) | 3.41161275 |
| 22 | indolalkylamine metabolic process (GO:0006586) | 3.40718362 |
| 23 | DNA dealkylation (GO:0035510) | 3.35037061 |
| 24 | protein K6-linked ubiquitination (GO:0085020) | 3.29807433 |
| 25 | prenylation (GO:0097354) | 3.29689335 |
| 26 | protein prenylation (GO:0018342) | 3.29689335 |
| 27 | DNA double-strand break processing (GO:0000729) | 3.24757824 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 3.18919500 |
| 29 | regulation of hypersensitivity (GO:0002883) | 3.16083211 |
| 30 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.15745209 |
| 31 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.14768062 |
| 32 | hematopoietic stem cell differentiation (GO:0060218) | 3.11711664 |
| 33 | coenzyme catabolic process (GO:0009109) | 3.07968365 |
| 34 | negative regulation of mast cell activation (GO:0033004) | 3.06562381 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06075605 |
| 36 | interferon-gamma production (GO:0032609) | 2.97485683 |
| 37 | B cell mediated immunity (GO:0019724) | 2.97232144 |
| 38 | negative regulation of bone resorption (GO:0045779) | 2.96103755 |
| 39 | detection of light stimulus involved in visual perception (GO:0050908) | 2.92636187 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.92636187 |
| 41 | negative regulation of viral genome replication (GO:0045071) | 2.92293165 |
| 42 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90888153 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90363238 |
| 44 | regulation of defense response to virus by host (GO:0050691) | 2.88044493 |
| 45 | replication fork processing (GO:0031297) | 2.85158859 |
| 46 | mRNA modification (GO:0016556) | 2.83500993 |
| 47 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.83163805 |
| 48 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.81286940 |
| 49 | positive regulation of protein homooligomerization (GO:0032464) | 2.80939669 |
| 50 | negative regulation of telomere maintenance (GO:0032205) | 2.80216066 |
| 51 | glycosphingolipid biosynthetic process (GO:0006688) | 2.79819961 |
| 52 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.77593215 |
| 53 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 2.76471530 |
| 54 | ketone body metabolic process (GO:1902224) | 2.74584053 |
| 55 | ADP metabolic process (GO:0046031) | 2.72961287 |
| 56 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.71465567 |
| 57 | T-helper 1 type immune response (GO:0042088) | 2.69702485 |
| 58 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.67234581 |
| 59 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.67234581 |
| 60 | adaptation of signaling pathway (GO:0023058) | 2.67086797 |
| 61 | protein polyglutamylation (GO:0018095) | 2.66577630 |
| 62 | defense response to virus (GO:0051607) | 2.63160253 |
| 63 | response to interferon-alpha (GO:0035455) | 2.62790572 |
| 64 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.59468591 |
| 65 | nucleoside diphosphate catabolic process (GO:0009134) | 2.56017766 |
| 66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55911745 |
| 67 | regulation of heat generation (GO:0031650) | 2.54964223 |
| 68 | positive regulation of catecholamine secretion (GO:0033605) | 2.54916891 |
| 69 | positive regulation of type 2 immune response (GO:0002830) | 2.54569809 |
| 70 | platelet dense granule organization (GO:0060155) | 2.52970801 |
| 71 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.51865813 |
| 72 | behavioral response to nicotine (GO:0035095) | 2.50977280 |
| 73 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.50738725 |
| 74 | ubiquinone biosynthetic process (GO:0006744) | 2.50215412 |
| 75 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.50190668 |
| 76 | response to nerve growth factor (GO:1990089) | 2.50190668 |
| 77 | cellular response to interferon-alpha (GO:0035457) | 2.49372269 |
| 78 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.49209098 |
| 79 | mitochondrial DNA replication (GO:0006264) | 2.48909152 |
| 80 | response to interferon-beta (GO:0035456) | 2.46855739 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45512188 |
| 82 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.45495148 |
| 83 | positive regulation of protein kinase C signaling (GO:0090037) | 2.42995721 |
| 84 | sulfate transmembrane transport (GO:1902358) | 2.41682240 |
| 85 | centriole replication (GO:0007099) | 2.39713726 |
| 86 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.39058188 |
| 87 | T cell lineage commitment (GO:0002360) | 2.38415196 |
| 88 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.36477721 |
| 89 | regulation of action potential (GO:0098900) | 2.35739734 |
| 90 | regulation of T-helper cell differentiation (GO:0045622) | 2.35737198 |
| 91 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.34053921 |
| 92 | regulation of cAMP-mediated signaling (GO:0043949) | 2.33794401 |
| 93 | acrosome assembly (GO:0001675) | 2.32314949 |
| 94 | myeloid dendritic cell differentiation (GO:0043011) | 2.32210922 |
| 95 | L-fucose catabolic process (GO:0042355) | 2.32056164 |
| 96 | fucose catabolic process (GO:0019317) | 2.32056164 |
| 97 | L-fucose metabolic process (GO:0042354) | 2.32056164 |
| 98 | double-strand break repair via homologous recombination (GO:0000724) | 2.32026329 |
| 99 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.30959021 |
| 100 | ubiquinone metabolic process (GO:0006743) | 2.30884601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.57166341 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12604479 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.32261219 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.23168946 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.12810939 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.02361610 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.99904074 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.95496052 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.88041795 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73230212 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.73079618 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.57603340 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36910593 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30761421 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.14929560 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.13564795 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.11336453 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.08856868 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86271539 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86215417 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85214646 |
| 22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.83250646 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83219201 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.81191016 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80892621 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75147677 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73571314 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.72846621 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.67978607 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67073628 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.62948187 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61138376 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59171506 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56404235 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44226200 |
| 36 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44226200 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43609510 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40740068 |
| 39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34736170 |
| 40 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34736170 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33854305 |
| 42 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.32575835 |
| 43 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.31795862 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29861282 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29053276 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28742038 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27801927 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26053228 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25807572 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25150840 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22544844 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22277161 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21318862 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21314230 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19996148 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19264395 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19264395 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18646136 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17021056 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15318806 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14275280 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12181264 |
| 63 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11091181 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09857554 |
| 65 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08380375 |
| 66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08153704 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07920847 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07870288 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05818285 |
| 70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05016830 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04961125 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04410182 |
| 73 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04318308 |
| 74 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03974081 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02986605 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.02756514 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.02756514 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02275137 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01302907 |
| 80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01166579 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01074194 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01029739 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00736961 |
| 84 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00471552 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00329767 |
| 86 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99629806 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99157453 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99025269 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98458835 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97239887 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94540983 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94232167 |
| 93 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94052006 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93732224 |
| 95 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93480212 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91718755 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90889968 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90155488 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89907014 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89869307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 4.50975794 |
| 2 | MP0005671_abnormal_response_to | 3.24491820 |
| 3 | MP0000013_abnormal_adipose_tissue | 2.97276100 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.83684357 |
| 5 | MP0000685_abnormal_immune_system | 2.69964019 |
| 6 | MP0005387_immune_system_phenotype | 2.42712863 |
| 7 | MP0001790_abnormal_immune_system | 2.42712863 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.35372685 |
| 9 | MP0001800_abnormal_humoral_immune | 2.19290899 |
| 10 | MP0009785_altered_susceptibility_to | 2.09174333 |
| 11 | MP0005310_abnormal_salivary_gland | 1.90230732 |
| 12 | MP0003195_calcinosis | 1.89577637 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 1.89304087 |
| 14 | MP0002736_abnormal_nociception_after | 1.87449340 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 1.77138122 |
| 16 | MP0001984_abnormal_olfaction | 1.75331627 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 1.72764846 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 1.70857305 |
| 19 | MP0002163_abnormal_gland_morphology | 1.70498830 |
| 20 | MP0004043_abnormal_pH_regulation | 1.68787668 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.67219802 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.67128210 |
| 23 | MP0003724_increased_susceptibility_to | 1.65999113 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.62255395 |
| 25 | MP0002723_abnormal_immune_serum | 1.61828733 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.60140741 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.54492016 |
| 28 | MP0005451_abnormal_body_composition | 1.52346155 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.49990771 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.40766381 |
| 31 | MP0003787_abnormal_imprinting | 1.39994523 |
| 32 | MP0009046_muscle_twitch | 1.37474935 |
| 33 | MP0008872_abnormal_physiological_respon | 1.36642849 |
| 34 | MP0002102_abnormal_ear_morphology | 1.34211427 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.32939509 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.30490832 |
| 37 | MP0001819_abnormal_immune_cell | 1.30328173 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.29253625 |
| 39 | MP0003646_muscle_fatigue | 1.26628496 |
| 40 | MP0005025_abnormal_response_to | 1.25167481 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.24918168 |
| 42 | MP0001764_abnormal_homeostasis | 1.22844791 |
| 43 | MP0005253_abnormal_eye_physiology | 1.22764259 |
| 44 | MP0008057_abnormal_DNA_replication | 1.22451191 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.20279743 |
| 46 | MP0001529_abnormal_vocalization | 1.19536047 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.18862342 |
| 48 | MP0000371_diluted_coat_color | 1.17421645 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.16011303 |
| 50 | MP0000716_abnormal_immune_system | 1.15286258 |
| 51 | MP0006082_CNS_inflammation | 1.15082995 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.14999925 |
| 53 | MP0004142_abnormal_muscle_tone | 1.13784833 |
| 54 | MP0003303_peritoneal_inflammation | 1.12550783 |
| 55 | MP0009840_abnormal_foam_cell | 1.12375258 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.12302660 |
| 57 | MP0000749_muscle_degeneration | 1.09858658 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.06652325 |
| 59 | MP0002398_abnormal_bone_marrow | 1.04129711 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.02436430 |
| 61 | MP0002006_tumorigenesis | 1.01955824 |
| 62 | MP0001502_abnormal_circadian_rhythm | 0.99221451 |
| 63 | MP0000427_abnormal_hair_cycle | 0.98971689 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98727948 |
| 65 | MP0010094_abnormal_chromosome_stability | 0.97694648 |
| 66 | MP0001845_abnormal_inflammatory_respons | 0.96027239 |
| 67 | MP0009745_abnormal_behavioral_response | 0.95950871 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 0.95322348 |
| 69 | MP0008961_abnormal_basal_metabolism | 0.94626526 |
| 70 | MP0002933_joint_inflammation | 0.94486454 |
| 71 | MP0002693_abnormal_pancreas_physiology | 0.93804828 |
| 72 | MP0002272_abnormal_nervous_system | 0.93629030 |
| 73 | MP0000689_abnormal_spleen_morphology | 0.89867530 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.89453175 |
| 75 | MP0002735_abnormal_chemical_nociception | 0.87353107 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 0.85244445 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.84553022 |
| 78 | MP0008058_abnormal_DNA_repair | 0.82303799 |
| 79 | MP0000613_abnormal_salivary_gland | 0.81967850 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.80449083 |
| 81 | MP0002429_abnormal_blood_cell | 0.80436270 |
| 82 | MP0009764_decreased_sensitivity_to | 0.78241443 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.77928119 |
| 84 | MP0002064_seizures | 0.77297365 |
| 85 | MP0003880_abnormal_central_pattern | 0.77126856 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.76632341 |
| 87 | MP0002722_abnormal_immune_system | 0.76536489 |
| 88 | MP0002254_reproductive_system_inflammat | 0.75210320 |
| 89 | MP0003633_abnormal_nervous_system | 0.73898370 |
| 90 | MP0005266_abnormal_metabolism | 0.73680392 |
| 91 | MP0005386_behavior/neurological_phenoty | 0.73447678 |
| 92 | MP0004924_abnormal_behavior | 0.73447678 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.73403853 |
| 94 | MP0008469_abnormal_protein_level | 0.72551774 |
| 95 | MP0003045_fibrosis | 0.71411797 |
| 96 | MP0002210_abnormal_sex_determination | 0.70348816 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.70347566 |
| 98 | MP0003786_premature_aging | 0.70272927 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.70244561 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.69435815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renal cortical cysts (HP:0000803) | 4.20844766 |
| 2 | Abnormality of the renal cortex (HP:0011035) | 3.76790357 |
| 3 | Hyperventilation (HP:0002883) | 3.30880963 |
| 4 | Generalized hypopigmentation of hair (HP:0011358) | 3.10118639 |
| 5 | Abnormality of the labia minora (HP:0012880) | 3.00770269 |
| 6 | Pancreatic cysts (HP:0001737) | 2.94581305 |
| 7 | Recurrent sinusitis (HP:0011108) | 2.82049180 |
| 8 | Attenuation of retinal blood vessels (HP:0007843) | 2.79574379 |
| 9 | Abnormality of lateral ventricle (HP:0030047) | 2.63227030 |
| 10 | Absent speech (HP:0001344) | 2.60941418 |
| 11 | Congenital stationary night blindness (HP:0007642) | 2.59213535 |
| 12 | IgA deficiency (HP:0002720) | 2.58083100 |
| 13 | Facial hemangioma (HP:0000329) | 2.56216986 |
| 14 | Molar tooth sign on MRI (HP:0002419) | 2.54925699 |
| 15 | Abnormality of midbrain morphology (HP:0002418) | 2.54925699 |
| 16 | Inability to walk (HP:0002540) | 2.48075580 |
| 17 | Clumsiness (HP:0002312) | 2.46073859 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 2.45897366 |
| 19 | Nephronophthisis (HP:0000090) | 2.45801361 |
| 20 | Stomach cancer (HP:0012126) | 2.44009558 |
| 21 | Broad-based gait (HP:0002136) | 2.43840222 |
| 22 | IgG deficiency (HP:0004315) | 2.43548578 |
| 23 | Pachygyria (HP:0001302) | 2.43034781 |
| 24 | Protruding tongue (HP:0010808) | 2.41709704 |
| 25 | Pancreatic fibrosis (HP:0100732) | 2.40505256 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.37832261 |
| 27 | Abnormality of the renal medulla (HP:0100957) | 2.35506140 |
| 28 | Type II lissencephaly (HP:0007260) | 2.34910133 |
| 29 | Abnormality of B cell number (HP:0010975) | 2.31569195 |
| 30 | Lymphopenia (HP:0001888) | 2.30314252 |
| 31 | Chronic hepatic failure (HP:0100626) | 2.25869735 |
| 32 | Intellectual disability, progressive (HP:0006887) | 2.24970464 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 2.22413956 |
| 34 | Recurrent bronchitis (HP:0002837) | 2.20994566 |
| 35 | Optic neuritis (HP:0100653) | 2.19324857 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.19324857 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18747574 |
| 38 | B lymphocytopenia (HP:0010976) | 2.17975290 |
| 39 | True hermaphroditism (HP:0010459) | 2.17851434 |
| 40 | Conical tooth (HP:0000698) | 2.09973990 |
| 41 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08315905 |
| 42 | Methylmalonic aciduria (HP:0012120) | 2.07288914 |
| 43 | Fair hair (HP:0002286) | 2.03028573 |
| 44 | Hypokalemic alkalosis (HP:0001949) | 2.01115338 |
| 45 | Decreased central vision (HP:0007663) | 2.00749551 |
| 46 | Methylmalonic acidemia (HP:0002912) | 2.00675743 |
| 47 | Anterior segment dysgenesis (HP:0007700) | 2.00151924 |
| 48 | Vasculitis (HP:0002633) | 1.99354475 |
| 49 | Proximal amyotrophy (HP:0007126) | 1.98938489 |
| 50 | Prostate neoplasm (HP:0100787) | 1.98620520 |
| 51 | Cone-rod dystrophy (HP:0000548) | 1.98577684 |
| 52 | Increased corneal curvature (HP:0100692) | 1.98281571 |
| 53 | Keratoconus (HP:0000563) | 1.98281571 |
| 54 | Gaze-evoked nystagmus (HP:0000640) | 1.96034763 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 1.90243477 |
| 56 | Optic disc pallor (HP:0000543) | 1.89971180 |
| 57 | Eosinophilia (HP:0001880) | 1.88586837 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 1.88390456 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88320426 |
| 60 | Polyuria (HP:0000103) | 1.87700887 |
| 61 | Lissencephaly (HP:0001339) | 1.87209587 |
| 62 | Generalized aminoaciduria (HP:0002909) | 1.86331940 |
| 63 | Abnormal albumin level (HP:0012116) | 1.85905179 |
| 64 | Hypoalbuminemia (HP:0003073) | 1.85905179 |
| 65 | Albinism (HP:0001022) | 1.81268473 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 1.79450482 |
| 67 | Abnormal glycosylation (HP:0012345) | 1.79450482 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.79450482 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.79450482 |
| 70 | Pendular nystagmus (HP:0012043) | 1.79330986 |
| 71 | Thyroiditis (HP:0100646) | 1.79326043 |
| 72 | Lipid accumulation in hepatocytes (HP:0006561) | 1.78946404 |
| 73 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77822896 |
| 74 | Neoplasm of the oral cavity (HP:0100649) | 1.76947947 |
| 75 | Prominent supraorbital ridges (HP:0000336) | 1.76311289 |
| 76 | IgM deficiency (HP:0002850) | 1.75976213 |
| 77 | Increased CSF lactate (HP:0002490) | 1.75189508 |
| 78 | Chronic otitis media (HP:0000389) | 1.74067266 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 1.73803482 |
| 80 | Carpal bone hypoplasia (HP:0001498) | 1.73329944 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 1.71742253 |
| 82 | Hypoplasia of the fovea (HP:0007750) | 1.71679638 |
| 83 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.71679638 |
| 84 | Recurrent cutaneous fungal infections (HP:0011370) | 1.71110915 |
| 85 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.71110915 |
| 86 | Progressive inability to walk (HP:0002505) | 1.71081700 |
| 87 | Intellectual disability, severe (HP:0010864) | 1.71068869 |
| 88 | Generalized hypopigmentation (HP:0007513) | 1.70334349 |
| 89 | Gonadotropin excess (HP:0000837) | 1.70183394 |
| 90 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.70090933 |
| 91 | Bile duct proliferation (HP:0001408) | 1.68252268 |
| 92 | Abnormal biliary tract physiology (HP:0012439) | 1.68252268 |
| 93 | Exocrine pancreatic insufficiency (HP:0001738) | 1.68162904 |
| 94 | Abolished electroretinogram (ERG) (HP:0000550) | 1.67888098 |
| 95 | Abnormality of macular pigmentation (HP:0008002) | 1.67059670 |
| 96 | Curly hair (HP:0002212) | 1.67025642 |
| 97 | Abnormality of the prostate (HP:0008775) | 1.65671818 |
| 98 | Esotropia (HP:0000565) | 1.65447438 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.64099550 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 1.64099550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 5.89133435 |
| 2 | ZAK | 5.33548363 |
| 3 | FRK | 4.09283163 |
| 4 | CASK | 3.60361728 |
| 5 | VRK1 | 3.36482106 |
| 6 | PINK1 | 2.74516412 |
| 7 | EIF2AK3 | 1.94023175 |
| 8 | ADRBK2 | 1.90734150 |
| 9 | BMPR1B | 1.85489323 |
| 10 | TAOK3 | 1.82506681 |
| 11 | MAP4K2 | 1.81332606 |
| 12 | OBSCN | 1.79093311 |
| 13 | NUAK1 | 1.71276350 |
| 14 | CCNB1 | 1.67917253 |
| 15 | STK38L | 1.61848130 |
| 16 | PNCK | 1.56294760 |
| 17 | GRK1 | 1.54787252 |
| 18 | WEE1 | 1.47388546 |
| 19 | IKBKE | 1.45147636 |
| 20 | TNIK | 1.43568520 |
| 21 | WNK3 | 1.39763338 |
| 22 | PHKG2 | 1.39271878 |
| 23 | PHKG1 | 1.39271878 |
| 24 | MARK3 | 1.31686465 |
| 25 | MAP2K7 | 1.31530394 |
| 26 | MAPK13 | 1.27694999 |
| 27 | RPS6KA5 | 1.24411877 |
| 28 | MST4 | 1.23015864 |
| 29 | CSNK1G3 | 1.17780489 |
| 30 | IKBKB | 1.16484288 |
| 31 | STK24 | 1.15040951 |
| 32 | TXK | 1.13753590 |
| 33 | PRKCQ | 1.12629665 |
| 34 | BLK | 1.12294841 |
| 35 | IRAK1 | 1.07167163 |
| 36 | MELK | 1.06858325 |
| 37 | MAP4K1 | 1.05826826 |
| 38 | JAK1 | 1.04712038 |
| 39 | CSNK1G2 | 1.03546144 |
| 40 | MAP3K4 | 1.02124675 |
| 41 | MARK1 | 0.99260939 |
| 42 | PKN1 | 0.98350405 |
| 43 | SIK2 | 0.94968945 |
| 44 | CSNK1A1L | 0.94668663 |
| 45 | CSNK1G1 | 0.92810599 |
| 46 | PIM1 | 0.91261016 |
| 47 | IRAK2 | 0.90256961 |
| 48 | MAP3K14 | 0.89480997 |
| 49 | BCKDK | 0.87935530 |
| 50 | SYK | 0.86481046 |
| 51 | MAP3K5 | 0.83043247 |
| 52 | MAPKAPK5 | 0.73880656 |
| 53 | JAK3 | 0.70634462 |
| 54 | TYK2 | 0.68794212 |
| 55 | KIT | 0.67410310 |
| 56 | MAPKAPK3 | 0.64413038 |
| 57 | TRIM28 | 0.64371486 |
| 58 | SGK2 | 0.63386600 |
| 59 | TBK1 | 0.63086352 |
| 60 | TEC | 0.61892163 |
| 61 | VRK2 | 0.61834997 |
| 62 | CHUK | 0.60951284 |
| 63 | DYRK2 | 0.59830333 |
| 64 | DAPK2 | 0.57838246 |
| 65 | STK4 | 0.56997775 |
| 66 | LYN | 0.55940745 |
| 67 | NLK | 0.54011366 |
| 68 | PLK3 | 0.53233330 |
| 69 | JAK2 | 0.52556776 |
| 70 | CDK3 | 0.51681792 |
| 71 | TGFBR1 | 0.51449842 |
| 72 | IRAK4 | 0.51113215 |
| 73 | TIE1 | 0.50960270 |
| 74 | ACVR1B | 0.48426733 |
| 75 | STK3 | 0.48398210 |
| 76 | BCR | 0.46356564 |
| 77 | PDK2 | 0.45843016 |
| 78 | BTK | 0.42958017 |
| 79 | HIPK2 | 0.42408355 |
| 80 | PAK3 | 0.41711228 |
| 81 | GRK7 | 0.39965800 |
| 82 | INSRR | 0.39661292 |
| 83 | OXSR1 | 0.39565675 |
| 84 | MKNK2 | 0.39443454 |
| 85 | MAPK11 | 0.38288595 |
| 86 | CDK9 | 0.36902781 |
| 87 | TSSK6 | 0.36842446 |
| 88 | TAF1 | 0.33934210 |
| 89 | PRKAA1 | 0.32896247 |
| 90 | CSNK1A1 | 0.32193899 |
| 91 | ATM | 0.31750585 |
| 92 | ROCK1 | 0.31112293 |
| 93 | DAPK3 | 0.31058651 |
| 94 | KDR | 0.30367819 |
| 95 | ITK | 0.29323944 |
| 96 | CHEK2 | 0.28934134 |
| 97 | CDC7 | 0.28223879 |
| 98 | LCK | 0.23618531 |
| 99 | ATR | 0.23234714 |
| 100 | MATK | 0.21379469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.56770957 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.69237459 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.46644702 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.32825801 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.16440915 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.82592445 |
| 7 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.74245713 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.32461234 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17208258 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17083453 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.16184154 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93876012 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.93317060 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.88932557 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.77550139 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.77484782 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61397344 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58202098 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56730191 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.50632791 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42940085 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42185238 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33842909 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28858305 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27407978 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.26922612 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.24265137 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23973953 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.22267367 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22002574 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21516987 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15483207 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14591190 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11403824 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.11211097 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10247996 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.06352392 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04660102 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04108163 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02107586 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01470916 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99303493 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98912111 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96456057 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95591356 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95556274 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94817408 |
| 48 | Protein export_Homo sapiens_hsa03060 | 0.84750514 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82835013 |
| 50 | Alcoholism_Homo sapiens_hsa05034 | 0.78873708 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73888875 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72559463 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.71613790 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70530346 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 0.70015113 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69645374 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68163668 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67969301 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67281193 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.64741764 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63885033 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62789633 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62425370 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62354427 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62265451 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59693224 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59612635 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.55311974 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54183329 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54166077 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52682267 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51194256 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.50953717 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.48442917 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.48249409 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47987262 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47452465 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47092931 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44725876 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.42834430 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42487144 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41332671 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.40455976 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37841047 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36646149 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35866522 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35772288 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35733710 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32120077 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.31376243 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31293586 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30646469 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30255288 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27475710 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.26538541 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26532612 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23599461 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23188169 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22870849 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21838608 |

